Alpha-Emitter Nanoparticles for Rapid Target-Molecule Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic tests for infectious diseases face challenges in affordability, accessibility, and accuracy, particularly in low-to-middle income countries, where they either lack sensitivity or are too costly and time-consuming, leading to ineffective disease management and treatment.
Innovation Solution
Development of a diagnostic device using alpha particle radiation-emitting nanoparticles (rNPs) for detecting biomolecules, which are detected by a portable CMOS sensor without requiring specific temperatures or reagents, enhancing sensitivity and reducing costs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If RT-PCR tests are used to detect COVID RNA, then accuracy and sensitivity are improved, but cost and turnaround time increase
Solution Approach 1:
The patent replaces complex biochemical amplification mechanisms (PCR) with direct alpha particle detection. Instead of amplifying nucleic acids through enzymatic reactions, the system uses radioactive nanoparticles that emit alpha particles when bound to target molecules, enabling direct detection without amplification steps.
Solution Approach 2:
The patent changes the detection parameter from fluorescent signal intensity (requiring amplification) to alpha particle emission count. This parameter change allows detection at much lower concentrations of target molecules, eliminating the need for time-consuming amplification while maintaining high sensitivity.
2Loss of time
If rapid antigen tests are used, then cost and turnaround time are reduced, but sensitivity and accuracy decrease
Solution Approach 1:
The patent replaces optical detection mechanisms (fluorescence-based) with radiation detection (alpha particle counting). This substitution enables rapid testing like antigen tests while achieving sensitivity comparable to or exceeding PCR tests, as alpha particles provide a highly detectable signal even at low concentrations.
Solution Approach 2:
The patent changes the signal detection parameter from fluorescent intensity (which requires amplification for sensitivity) to alpha particle emission rate. This allows the test to achieve high sensitivity without amplification, maintaining rapid turnaround time while improving detection capability.
3Measurement precision
If complex biochemical methods are used for accurate testing, then measurement precision is improved, but device complexity and infrastructure requirements increase
Solution Approach 1:
The patent replaces complex biochemical systems (enzymes, incubators, washing steps) with a simpler radiation detection system. The alpha-emitting nanoparticles provide a direct detectable signal that can be read by a simple counter, eliminating the need for complex laboratory infrastructure while maintaining high accuracy.
Solution Approach 2:
The patent extracts the detection function from the complex biochemical process. Instead of relying on multiple biochemical steps (amplification, staining, washing, incubation), the system uses a single-step binding of radioactive nanoparticles to target molecules, followed by direct alpha particle detection, removing unnecessary complexity.
4Measurement precision
If amplification methods are used to detect low-concentration target molecules, then measurement precision is improved, but loss of time and device complexity increase
Solution Approach 1:
The patent substitutes amplification-based detection with direct detection using radioactive nanoparticles. The nanoparticles are designed to bind to target molecules at very low concentrations, providing sufficient signal without requiring amplification, thus eliminating the time loss associated with PCR or other amplification methods.
Solution Approach 2:
The patent changes the detection approach from signal amplification (increasing signal intensity through repeated copying) to direct signal detection (using highly sensitive alpha particle counting). This parameter change allows detection of low-concentration targets without time-consuming amplification steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device provides rapid, accurate, and affordable testing for infectious diseases, improving disease management and treatment selection by prioritizing sensitivity over specificity, thus catching asymptomatic carriers and reducing disease spread.
Implementation Method 1
alpha particle radioisotopes
Implementation Method 2
detecting target molecules using alpha particle radiation-emitting nanoparticles
Data Source
AI summary
A diagnostic device and method detect target molecules in a liquid sample using radioisotopes that undergo alpha decay. The liquid sample is introduced onto a first portion of a permeable membrane, where its target molecules chemically bind to molecular tags. Each molecular tag includes both an alpha-emitter and a capture molecule designed to bind to the target molecule. The sample, including any bound target molecules, undergoes capillary flow to a second portion of the membrane, where an alpha-particle detector detects any bound alpha-emitters. The alpha-emitters may be radioactive nanoparticles (e.g. polonium-210) coated with an environmental protectant (e.g. gold). The detector may include CMOS diodes or a charge-coupled device. The device may include an indicator that signals when the detector detects alpha-particles above a given threshold in the second portion.